Next Article in Journal
Sensory-Based Identification of Aroma-Active Compounds in Hotpot Seasoning before and after Boiling
Next Article in Special Issue
Intermediate Detection in the Casiopeina–Cysteine Interaction Ending in the Disulfide Bond Formation and Copper Reduction
Previous Article in Journal
A Study on the Behavior Patterns of Liquid Aerosols Using Disinfectant Chloromethylisothiazolinone/Methylisothiazolinone Solution
Previous Article in Special Issue
Nomad Jellyfish Rhopilema nomadica Venom Induces Apoptotic Cell Death and Cell Cycle Arrest in Human Hepatocellular Carcinoma HepG2 Cells
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Antioxidant Activity of Bioactive Peptide Fractions from Germinated Soybeans Conjugated to Fe3O4 Nanoparticles by the Ugi Multicomponent Reaction

by
Yarelys Elena Augusto-Jimenez
1,*,
Marcela González-Montoya
2,
Dany Naranjo-Feliciano
3,
Daniel Uribe-Ramírez
2,
Eliseo Cristiani-Urbina
2,
Carlos Díaz-Águila
4,
Hernani Yee-Madeira
1 and
Rosalva Mora-Escobedo
2,*
1
Instituto Politécnico Nacional–ESFM, U.P.A.L.M., San Pedro Zacatenco, Ciudad de Mexico 07738, Mexico
2
Instituto Politécnico Nacional–ENCB, U.P.A.L.M., San Pedro Zacatenco, Ciudad de Mexico 07738, Mexico
3
Centro Nacional de Sanidad Agropecuaria, San Jose de las Lajas 32700, Mayabeque, Cuba
4
Centro de Biomateriales, Universidad de La Habana, Plaza de la Revolucion 10400, La Habana, Cuba
*
Authors to whom correspondence should be addressed.
Molecules 2021, 26(19), 5726; https://doi.org/10.3390/molecules26195726
Submission received: 22 July 2021 / Revised: 7 September 2021 / Accepted: 13 September 2021 / Published: 22 September 2021
(This article belongs to the Special Issue Redox Active Molecules in Cancer Treatments)

Abstract

:
The conjugation of biomolecules to magnetic nanoparticles has emerged as promising approach in biomedicine as the treatment of several diseases, such as cancer. In this study, conjugation of bioactive peptide fractions from germinated soybeans to magnetite nanoparticles was achieved. Different fractions of germinated soybean peptides (>10 kDa and 5–10 kDa) were for the first time conjugated to previously coated magnetite nanoparticles (with 3-aminopropyltriethoxysilane (APTES) and sodium citrate) by the Ugi four-component reaction. The crystallinity of the nanoparticles was corroborated by X-ray diffraction, while the particle size was determined by scanning transmission electron microscopy. The analyses were carried out using infrared and ultraviolet–visible spectroscopy, dynamic light scattering, and thermogravimetry, which confirmed the coating and functionalization of the magnetite nanoparticles and conjugation of different peptide fractions on their surfaces. The antioxidant activity of the conjugates was determined by the reducing power and hydroxyl radical scavenging activity. The nanoparticles synthesized represent promising materials, as they have found applications in bionanotechnology for enhanced treatment of diseases, such as cancer, due to a higher antioxidant capacity than that of fractions without conjugation. The highest antioxidant capacity was observed for a >10 kDa peptide fraction conjugated to the magnetite nanoparticles coated with APTES.

Graphical Abstract

1. Introduction

The main challenges for magnetic nanoparticles (MNPs) used in biomedicine are related to their tendency to agglomerate and lack of biocompatibility [1]. Regarding biocompatibility, iron oxide nanoparticles (NPs) maghemite (γ-Fe2O3) and magnetite (Fe3O4) are advantageous for in vivo applications. Unlike other materials with good magnetic behavior, iron cell homeostasis is well-controlled by absorption, excretion, and storage processes. Even excess iron is efficiently removed from the body [2]. Specially, different works show that the superparamagnetic behavior of magnetite NPs is closely related to their nanometric size [3]. This property is essential for the in vivo applications of the material as it ensures that no magnetization remains in the system after stopping the action of an external magnetic field. Moreover, uncoated magnetite NPs tend to decrease the surface free energy by forming stable aggregates under physiological conditions [4]. In this regard, it has been observed that the coupling of different types of biomolecules to Fe3O4 NPs increases the stability of the system while directing it towards the desired biological target. Thereby, magnetite has been coupled to polymers and different anticancer drugs, with prominent applications in biomedicine, nanoscience, and nanotechnology [5,6,7]. These conjugates are of interest mainly because the benefits of the Fe3O4 NPs and biomolecules are combined in the same system.
Peptide–Fe3O4 conjugates are promising for biotechnological applications [8,9,10], particularly because peptides from natural sources and synthetic derivatives have been identified as promising for the treatment of diseases, such as cancer [11,12]. From the conjugation of peptides to Fe3O4 NPs, one could not only selectively transport drugs towards biological targets, but also treat different diseases using magnetic hyperthermia [13,14,15,16]. Despite the advances in the development of methodologies for the conjugation of peptides to magnetite NPs, the current protocols are still limited by long and complex reaction steps. In most cases, they are based on classical peptide coupling between peptides and MNPs functionalized with carboxylic acid groups [17]. In some studies, surface modification of MNPs has been performed with ligands suitable for their subsequent coupling to peptides through click chemistry [14]. This restricts and makes the application of peptide–Fe3O4 conjugates in biomedical investigations more expensive.
Several procedures for the combination of complex molecules based on multicomponent reactions have been reported [18,19]. Multicomponent protocols have a high potential owing to their high chemical efficiency, simple execution, and structural diversity at low synthesis costs [20]. One of the most used is the Ugi four-component (U-4C) reaction, in which the condensation of an oxo derivative, primary amine, carboxylic acid, and isonitrile leads to the formation of a dipeptoid in a single reaction step. The N-substituted amide in peptoids derived from the U-4C reaction is a structural motif of biological relevance because it prevents proteolytic degradation and limits the conformational orientation of peptide structures [21]. However, to the best of our knowledge, this type of reaction has not been used for the conjugation of bioactive peptides to MNPs.
On the other hand, several studies demonstrated the important role of oxidative stress and presence of different reactive oxygen and nitrogen species (ROS and RNS, respectively) in numerous noncommunicable diseases, such as cardiovascular diseases, diabetes, atherosclerosis, arthritis, and cancer [22]. These diseases lead to approximately 41 million deaths per year, equivalent to 71% of all deaths globally [23]. Some peptides and biomimetic peptides inhibit the generation of ROS and other free radicals [24,25]. Therefore, the search for antioxidant peptide structures that can prevent oxidative stress and its associated adverse effects is of increasing interest. In this sense, González-Montoya et al. evaluated the anti-inflammatory, antioxidant, and antiproliferative activities of three peptide fractions obtained from germinated soybeans [26,27]. These peptide fractions exhibited exceptional antioxidant and antiproliferative activities in breast and cervical cancer cell lines. Motivated by these studies, we present the synthesis, characterization, and biological evaluation of conjugates of Fe3O4 NPs with bioactive peptide fractions from germinated soybeans. To the best of our knowledge, these bioconjugates are reported for the first time. A multicomponent procedure is also used for the first time in the conjugation of bioactive peptide fractions from germinated soybeans to magnetite NPs.

2. Results and Discussion

A procedure for the conjugation of bioactive peptide fractions to magnetite NPs was developed (Scheme 1). The methodology comprised three fundamental parts: (1) synthesis of Fe3O4 NPs, (2) functionalization of Fe3O4 NPs in the form of either carboxylic acid or amine, and (3) conjugation using the U-4C reaction of the peptide fractions extracted from germinated soybeans to the functionalized Fe3O4 NPs. Once the desired conjugates were obtained, the antioxidant activity of both the peptide–Fe3O4 conjugates as well as the peptide fractions and coated magnetite were determined.

2.1. Characterization of Fe3O4

The X-ray diffraction (XRD) pattern of the synthesized magnetite is shown in Figure 1 (black profile). The main peaks associated with the characteristic spinel structure of magnetite were observed at 18.3, 30.2, 35.6, 43.3, 53.6, 57.3, 62.9, 74.5, and 90.6°. These peaks are indexed to the (111), (220), (311), (400), (422), (511), (440), (533), and (731) hkl planes of the Joint Committee on Powder Diffraction Standards (JCPDS) 19629 magnetite standard pattern, respectively. The estimated Fe3O4 cell parameter was 8.3824 Å and the average crystallite size calculated using the Debye–Scherrer equation (Equation (1)) was 17 nm. This last value allowed confirming the nanometric size of the obtained magnetite.
Additional information about the size and morphology of Fe3O4 NPs was obtained using scanning transmission electron microscopy (STEM) (Figure 2). The particle size determined was 13 ± 5 nm. The fact that this value is similar to the calculated crystallite size suggests that the system was monocrystalline. In the STEM images, it is observed that uncoated Fe3O4 NPs have spherical morphology and are agglomerated, most likely because of their small sizes.
The synthesis of Fe3O4 was also corroborated by infrared (IR) spectroscopy (Figure 3, black spectrum). From the assignment of the absorption bands observed in the IR spectra obtained, it was possible to analyze the respective functional groups of the molecules present in each of the synthesized materials. Thus, a broad band centered at 3252 cm−1, corresponding to the overlapping valence vibrations of the N–H and O–H bonds, was observed. It was assigned to NH4+ and OH ions and adsorbed water molecules on the surface of MNPs. In addition, the band at 1628 cm−1 can be attributed to the bending of the NH4+ group on the magnetite surface. Finally, at 573 cm−1, a band assigned to the valence vibration of the Fe–O bond of Fe3O4 was observed.
Finally, the hydrodynamic diameter of Fe3O4 was determined using dynamic light scattering (DLS) measurements. The value obtained (180 ± 70 nm) was used as a reference for comparison to the coated magnetite samples.

2.2. Characterization of the Functionalized Fe3O4

As mentioned in the Introduction, though magnetite is a biocompatible material, its stabilization in a physiological environment is only possible after coating [2,4]. In addition, functionalization enables the conjugation with therapeutic biomolecules and contributes to achieving effective directionality of magnetite nanoparticles towards the site of interest inside the body [7]. In this work, it was decided to carry out the coating/functionalization of the Fe3O4 NPs in a single step. Thus, from the use of sodium citrate and 3-aminopropyltriethoxysilane (APTES), it was possible to functionalize the magnetite surface in the form of carboxylic acid and amine, respectively. Both functional groups are required for subsequent conjugation to the peptide fractions from the Ugi 4C reaction. Each of the variants made is described below.

2.2.1. Characterization of Fe3O4@citrate

Carboxylate is one of the functional groups that most strongly binds to the surface of magnetite NPs [28]. Sodium citrate (or the corresponding acid), a small biocompatible molecule, has three carboxylate groups in its structure. Only one or two of the carboxylate functions of sodium citrate have been found to coordinate to the magnetite surface, allowing at least one of them to be exposed to the medium [29]. This effect is very convenient for the application of the magnetic system since it protects the nanoparticulate nucleus from the possible formation of aggregates while providing it with hydrophilicity and functionalizing it for subsequent derivatizations and couplings. Here, after the synthesis of Fe3O4 NPs coated with sodium citrate (Fe3O4@citrate), the resulting product was characterized.
The Fourier-transform infrared (FTIR) spectroscopy analysis of the MNPs coated with sodium citrate suggested that the desired product was obtained (Figure 3, blue spectrum). The three bands at 3435, 1629, and 1398 cm−1 indicate carboxylate in the sample. These signals correspond to the valence vibrations of the O–H, C=O, and COO– bonds, respectively. The band corresponding to Fe3O4 remained at 537 cm−1. In addition, the XRD patterns of the starting magnetite (Figure 1, black profile) and that coated with citrate (Figure 1, blue profile) were similar, which suggests that the crystallinity of the material was not affected by the coating. However, the calculated cell parameter was 8.3643 Å. The difference with respect to the cell parameter of the uncoated magnetite indicates a strong interaction between citrate atoms and magnetite, which results in the contraction of the unit cell of the starting material [30]. The average crystallite size determined using the Debye–Scherrer equation (Equation (1)) was 16 nm. This value is similar to the particle size estimated using STEM (13 ± 3 nm). The similarity between these results suggests that the compound was monocrystalline. Figure 4a shows a microscopy image and obtained size distribution with the corresponding histogram. The obtained NPs had spherical morphology with some aggregation because of their small sizes.
Another evidence of the presence of citrate on the surface of the MNPs is the increase in the hydrodynamic diameter (284 ± 140 nm) relative to that of the uncoated MNPs. As some of the polar groups of citrates (carboxylate and hydroxyl) are dangling towards the surrounding medium, a larger hydration layer is generated. Finally, the weight percentage of the coating material on magnetite, with respect to the uncoated Fe3O4, was determined using thermogravimetric analysis (TGA). The weight loss was 2.21%, confirming that magnetite was coated with an organic material.

2.2.2. Characterization of Fe3O4@APTES

The functionalization of the Fe3O4 NPs surface in the amine form was carried out from a silylation reaction with the use of APTES. This molecule is the most widely used alkoxysilane for coating magnetite NPs since it provides the highest density of amine groups on the surface of the magnetic core [31].
The IR spectrum of Fe3O4@APTES showed characteristic bands that confirmed the presence of the expected APTES coating (Figure 3, green spectrum). Thus, a wide band, centered at 3399 cm−1, was observed, attributed to the overlapping valence vibrations of the O–H and N–H bonds of the hydroxyl and amine groups in APTES. The bands corresponding to the antisymmetric and symmetric vibrations of the APTES methylene groups appeared at 2928 and 2842 cm−1, respectively. The bands corresponding to the vibrations antisymmetric and symmetric of the NH2 group in APTES were observed around 1642 and 1549 cm−1, respectively. The presence of silanol groups (Si–OH) and siloxanes (Si–O–Si) on the surface of the MNPs was verified by the bands of the valence vibrations of the Si–O–Si and Si–OH bonds at 1396 and 1015 cm−1, respectively. Finally, the Fe3O4 band was maintained at 573 cm−1, suggesting the presence of magnetite in the conjugate. Moreover, no differences were observed between the XRD patterns of the coated and uncoated magnetite samples (Figure 1, green and black profile, respectively), which confirms that the crystallinity of the material was not affected by the coating with APTES.
The calculated cell parameter of Fe3O4@APTES was 8.3744 Å, slightly lower than that determined for the uncoated magnetite, as the Fe and O atoms are closer to each other in the unit cell owing to the APTES molecules [30]. The crystallite size of the APTES-coated NPs was 17 nm, which confirms that the compound maintained its nanoscale dimensions. This value is very similar to the particle size obtained using STEM (16 ± 3 nm), which suggests that the system was monocrystalline. The STEM images (Figure 4b) show that the coated NPs have spherical morphology and are agglomerated because of their small sizes. The weight percentage of the APTES-coated Fe3O4 was determined using TGA. A weight loss of 5.22% with respect to the uncoated Fe3O4 was obtained, which confirmed the coating on the magnetite surface.

2.3. Determination of the Degree of Substitution of Functionalized MNPs

The degree of substitution on the magnetic oxide was assessed, i.e., the amount of free functional groups on the surface of Fe3O4. For this purpose, the adsorption capacity of Cu (II) on the functionalized MNPs was determined using a spectrophotometric analysis. The results are presented in Table 1. To assess the molar quantity of free carboxylate groups on the MNPs coated with sodium citrate, it was considered that 2 M of carboxylate is necessary to complex 1 M of Cu2+. In the case of MNPs coated with APTES, it was assumed that the Cu2+ ions would form a complex with tetrahedral geometry with free amine groups on the magnetite [32]. Using this procedure, approximate molar quantities of free carboxylates or amine groups per gram of Fe3O4 were obtained.
The calculations for the subsequent synthesis step were carried out using the average value of the loading of functional groups on the Fe3O4 surface.

2.4. Characterization of Peptide–Fe3O4 Conjugates

The main objective of this study was to develop a simple procedure for the conjugation of bioactive peptide fractions extracted from germinated soybeans to magnetite NPs. To this end, the U-4C reaction was chosen because it occurs in a single step and can be easily implemented [33,34]. The results for the remaining peptide concentrations are shown in Figure 5. There were no statistically significant differences in the percentage of free peptides at 4 and 8 h in either variant for the same peptide fraction. This suggests that the reaction ended after 4 h. However, the difference between the percentages of conjugation when the fraction >10 kDa was used (approximately 60%) and that at 5–10 kDa (approximately 92%) was remarkable. This was expected considering the smaller size of the peptides contained in the latter, which would facilitate the multicomponent process. On the other hand, the yields of the developed conjugation process can be considered good in all the cases, considering that the magnetic component of the reaction is solid-support-dispersed, while the other reactants are dissolved in the medium [35].
The conjugates were characterized using FTIR spectroscopy (Figure 6). In all the cases, the bands that confirmed the presence of carbonyl groups in each of the structures on the MNPs were observed at approximately 1620 cm−1. In addition, the band at 573 cm−1 was retained, which corroborated the presence of Fe3O4.

2.5. Antioxidant Activities of the Conjugates

The association between the generation of ROS and the development of chronic degenerative diseases has been reported [27]. Furthermore, in cellular metabolism, oxidative compounds are produced constantly, so it is important to counteract these oxidizing spices to maintain a balance of intra- and extracellular homeostasis. Hence, the antioxidant capacities of the conjugates obtained in this study were evaluated. The determinations were made by verifying their reducing power (RP) and hydroxyl radical (OH·) scavenger abilities. The results presented below (Figure 7 and Figure 8) correspond to the tests carried out at a concentration of 15 mg/mL, at which a stronger effect was observed in the determinations. All the results were compared to those obtained for the nonconjugated peptide fractions and for the coated magnetite (Fe3O4@APTES and Fe3O4@citrate).
The RPs of the coated magnetite, as well as those of the conjugates and nonconjugated peptide fractions (Figure 7), were expressed as absorbances, where 1 represents the highest value. The RP of a sample refers to its ability to act as a proton acceptor (or electron donor) in an oxidation–reduction reaction and, therefore, the number of basic groups in the conjugates could be related to the obtained RP. In this sense, Fe3O4@APTES, with free amine groups on the magnetite surface, showed the highest RP value. Regarding the conjugates, those in which magnetite was conjugated to the fractions containing the peptides with masses >10 kDa (conjugates 1 and 3) had the highest RP values, with statistically significant differences between them and the conjugates 2 and 4. This result agrees with the study by González-Montoya et al. [27], who observed that the >10 kDa (RP = 0.7) fraction had a higher RP than the 5–10 kDa fraction (RP = 0.3). This could be attributed to the higher amount of basic amino acids in the >10 kDa fraction. A synergistic effect was observed when conjugating the peptide fractions to Fe3O4@APTES (conjugate 3 with respect to the >10 kDa peptide fraction), surely, due to the contribution of the amine groups that remained free, unreacted during the multicomponent reaction, on the surface of the magnetite coated with the APTES. It was also observed that the conjugation of the >10 kDa peptide fraction to magnetite NPs coated with sodium citrate (conjugate 1) slightly decreased the RP with respect to that of the peptide fraction, whilst the RP of the 5–10 kDa peptide fraction conjugated to Fe3O4@citrate (conjugate 2) did not exhibit statistically significant differences with respect to the nonconjugated fraction. In this way, conjugate 3 represents an opportunity for future evaluations of biological activities related with oxidative stress in chronic diseases.
The hydroxyl radical (OH·) is one of the most reactive free radicals and is generated by the Fenton reaction in cells [27]. This radical can be transformed into a superoxide anion and hydrogen peroxide in the presence of metal ions such as copper and iron. The OH· scavenging activities of the coated magnetite (Fe3O4@APTES and Fe3O4@citrate), as well as those of the conjugates and nonconjugated peptide fractions, are shown in Figure 8. According to the data, the nature of the groups exposed to the medium on each sample determines the properties of the compound. In the case of conjugates with the fraction > 10 kDa (conjugates 1 and 3), the activity is higher when it is used as an acidic component of the multicomponent reaction (conjugate 3). Therefore, in the final compound, the peptides would mostly expose their amine groups (which are apparently involved in the measured activity) to the environment. In the conjugates with the 5–10 kDa fraction (conjugates 2 and 4), the opposite effect was observed. The peptides contained in this fraction exerted a stronger OH· scavenging effect by exposing their acidic groups (conjugate 2). Remarkably, the OH· scavenging activities of conjugates 2 and 3 were significantly higher than that of the nonconjugated fractions. This result could be due to a synergistic effect of the respective carboxylic acid (from Fe3O4@citrate) and amine (from Fe3O4@APTES) groups in the corresponding final conjugates.
These results suggest that conjugates 2 and 3 could be a used as antioxidant conjugates and evaluated in the future in chronic diseases related with oxidative stress, such as cancer since it has been reported that antioxidant activity can modulate the activity of key proteins involved in the control of cell cycle progression and may influence the expression of many associated genes [36].

3. Materials and Methods

3.1. Materials

Ferrous chloride tetrahydrate (FeCl2·4H2O, PA), sodium citrate dihydrate (Na3C6H5O7·2H2O, ACS >99%), APTES (97%), paraformaldehyde, 1-pentynylisonitrile, trichloroacetic acid (TCA), phenanthroline, and ferrous sulphate (FeSO4) were purchased from Sigma-Aldrich, Mexico City, Mexico. Ferric chloride hexahydrate (FeCl3·6H2O, 99.0%) and the ammonium hydroxide solution (NH4OH, 28.4%) were purchased from J.T. Baker, Mexico City, Mexico. Hydrochloric acid (HCl, PA) and potassium ferricyanide (K3[Fe(CN)6]) were purchased from Fermont, Monterrey, Mexico, and hydrogen peroxide (H2O2) from Reasol, Mexico city, Mexico. The peptide fractions were supplied by Laboratorio de Bioquímica de la Nutrición (ENCB-IPN), Mexico City, Mexico.

3.2. Synthesis of Fe3O4 NPs

The NPs were synthesized using the coprecipitation method [37]. A mixture of acidic solutions (HCl, 2 M) of the FeCl2·2H2O (5 mL, 5 M) and FeCl3·6H2O (20 mL, 2.5 M) salts was added to an aqueous solution of NH3 (250 mL, 0.7 M) contained in a three-neck balloon using a peristaltic pump. All the solutions were bubbled with N2 (g) before the synthesis. The reaction mixture was kept at room temperature under an N2 (g) atmosphere under mechanical stirring (500 rpm) and ultrasound-treated for 25 min. After the reaction time, the obtained MNPs were separated using a neodymium magnet. Subsequently, they were washed with 100 mL of deionized water and separated again to obtain a black powder corresponding to Fe3O4, which was dried in a desiccator containing activated silica for 12 h.

3.3. Coating/Functionalization of Fe3O4 NPs

3.3.1. Fe3O4@citrate

The functionalization of the MNPs as carboxylic acids was carried out by coating Fe3O4 with sodium citrate. Fe3O4 (500 mg) was added to an aqueous solution of Na3C6H5O7·2H2O (50 mL, 1 mM). The reaction mixture was mechanically stirred for 4 h at room temperature, and then adjusted to pH = 9 using an aqueous solution of NH3 (0.7 M). The obtained precipitate was magnetically separated and washed twice with 50 mL of deionized water. Finally, it was dried (as explained for the synthesis of the Fe3O4 NPs), and Fe3O4@citrate was obtained in the form of a black powder.

3.3.2. Fe3O4@APTES

Additionally, the functionalization of the MNPs as amines was carried out by modifying the surface of Fe3O4 with APTES [31]. Briefly, 500 mg of Fe3O4 were redispersed in a mixture of ethanol (80 mL) and deionized water (40 mL). The dispersion was adjusted to pH = 10 with an aqueous solution of NH3 (0.7 M) and homogenized in an ultrasonic bath. Subsequently, an alcoholic solution of APTES (5 mL, 10%) was dripped to the reaction mixture under constant stirring. After 24 h, the precipitate was separated with a neodymium magnet and washed twice with 50 mL of ethanol. Finally, the product was dried according to the procedure described above to obtain Fe3O4@APTES in the form of a black powder.

3.4. Cu(II) Adsorption Capacity of Functionalized NPs

Once the functionalization of MNPs was completed, the degree of substitution on the magnetic oxide was calculated. The determination could be carried out using the bicinchoninate method from the quantification of Cu(II) ions remaining in aqueous dispersions [38]. An aqueous solution of CuSO4·5H2O (35.5 mL, 100 mg/L) was prepared in an Erlenmeyer flask. Subsequently, 5 mL of the solution were collected, and a bicinchoninic acid kit was added. The absorbance was measured using an ultraviolet (UV)–visible (Vis) spectrophotometer at 560 nm (time: 0 h), and then the concentration was determined. The functionalized MNP sample (0.03 g) was added to the remaining solution (30.5 mL) and the pH was adjusted to 5 with HCl (0.1 M). The reaction mixture was mechanically stirred with a glass-lined magnetic stirrer at 140 rpm for 1 h. The magnetic system was then separated with a neodymium magnet. The supernatant (0.25 mL) was then collected, filtered, and diluted with 4.75 mL of distilled water, and a bicinchoninic acid kit was added. The absorbance was measured at 560 nm (time: 1 h), and then the concentration was determined. The last absorbance measurement was performed 24 h after the functionalized MNPs were in contact with CuSO4·5H2O (time: 24 h). Each measurement was performed in duplicate.

3.5. Synthesis of Peptide–Fe3O4 Conjugates by the U-4C Reaction

To conjugate the peptide fractions to Fe3O4 using the U-4C reaction, the amino component (the peptide fractions or Fe3O4@APTES) and four equivalents (eq) of paraformaldehyde were reacted at room temperature for 24 h in the smallest required volume of phosphate-buffered saline (PBS) (pH = 7.4). The acid component (Fe3O4@citrate or peptide fractions) was then added; 10 min later, 1-pentynylisonitrile (4 eq) was added. The reactions were monitored at intervals of 4 h over 8 h and carried out in quintuplicate. Finally, the products were washed twice with 1 mL of distilled water and dried, as stated for the synthesis of Fe3O4 NPs.

3.6. Extension of the Conjugation

The amount of peptide remaining after conjugation to MNPs by the U-4C reaction was determined according to the Bradford assay [39]. The supernatants of each reaction (10 μL) were deposited with 100 μL of the Bradford reagent in a 96-well microplate. The readings were carried out at a wavelength of 595 nm. The remaining peptide concentration values were determined using a calibration curve of bovine serum albumin (BSA).

3.7. NP Characterizations Using X-ray Diffraction, Fourier-Transform Infrared Spectroscopy, Scanning Transmission Electron Microscopy, Thermogravimetric Analysis, Dynamic Light Scattering, and Spectrophotometric Analysis

XRD measurements were performed using a Bruker D8 Advance diffractometer. Cu Kα (λ = 1.54183 Å) incident radiation was used. The measurements were carried out in the range of 5–100° with an increment of 0.02° and scan speed of 10 s. The cell parameters were calculated using the Powdercell 2.4 software. The average crystallite size was determined using the Debye–Scherrer equation (Equation (1))
D =   κ λ β cos θ .
where D is the crystallite size, κ is the Debye–Scherrer constant (0.89), λ is the operation wavelength, β is the average width of the most intense peak, and θ is the Bragg angle.
FTIR spectra were recorded using an Equinox 55 Bruker spectrometer in the absorbance measurement range of 4000 to 400 cm−1. TGA measurements were performed using a Netzsch STA 409 PC Luxx thermal analyzer coupled to the FTIR equipment. Approximately 10 mg of the sample were heated from 25 to 1000 °C and analyzed at the heating flux of 20 °C/min in an Ar atmosphere. DLS measurements were carried out using a Zetasizer Nano sampler (Malvern Instruments, Cambridge, UK) equipped with a He–Ne laser (λ = 633 nm). The measurements were carried out in square polystyrene cells at 25 °C in the range of 0.3–10 μm using H2O as a dispersion medium. The absorbance performance was assessed using two different types of equipment. To determine the adsorption capacity of Cu2+ ions, the absorbance values were obtained at 560 nm using a Genesys 10 UV spectrophotometer (Thermo Electron Corporation, Madison, WI, USA). During the experiment with the peptide fractions, the absorbances were measured using a microplate reader (Thermo Scientific Multiskan GO, Waltham, MA, USA). The readings were carried out at 536, 595, and 700 nm depending on the system and properties to be determined. The morphology and average size of the NPs were analyzed using STEM images. The measurements were carried out using a JEM-ARM200CF electronic microscope with the resolution of 80 pm for the employed mode. The acceleration voltage was 200 keV. The analysis of the STEM images to determine the NP average size was carried out with the ImageJ (Origin(Pro) Corporation, Northampton, MS, USA), and the histograms were obtained using Origin v9.0, (OriginLab Corporation, Northampton, MS, USA).

3.8. In Vitro Determination of the Antioxidant Activity of the Samples

3.8.1. Reducing Power (RP)

The RP of the conjugates was determined according to the method described by Oyaizu et al. [40]. It is based on the reduction of ferricyanide [Fe(CN)6]−3 to the ferrocyanide [Fe(CN)6]−4 anion. Owing to this reduction, Prussian blue was formed in the presence of Fe3+. PBS (0.2 M, pH = 6.6; 50 μL) and 50 μL of K3[Fe(CN)6] (1%) were added to 20 μL of the samples at the concentrations of 15, 7.5, 3.75, and 1.88 mg/mL in one 96-well microplate. The mixture was incubated at 40 °C for 20 min. Subsequently, 50 μL of TCA (10%) and 10 μL of FeCl3 (0.1%) were added and incubated for 10 min at 40 °C. The absorbance was read at 700 nm using a microplate reader.

3.8.2. Hydroxyl Radical Scavenging Activity

The percentage hydroxyl radical (OH·) scavenging capacity of the conjugates was determined according to the method developed by Lin et al. [41]. In this procedure, OH· is generated using the Fenton reaction. Thus, 20 μL of each sample at the concentrations of 15, 7.5, 3.75, and 1.88 mg/mL were placed in a 96-well microplate. Subsequently, 50 μL of 1,10-phenanthroline and FeSO4 (3 mM) were added. To start the reaction, 50 μL of H2O2 were added and incubated at 37 °C for 60 min. The absorbance was measured using a microplate reader at 536 nm.

3.9. Statistical Analysis

The statistical analysis of the data obtained during the determination of the extension of conjugation and the antioxidant activity tests was performed using GraphPad Prism v6.0, La Jolla, CA, USA. A one-way analysis of variance (ANOVA) and Tukey’s test were performed for multiple comparisons. The statistical significance was set at p ≤ 0.05.

4. Conclusions

The conjugation of peptide fractions from germinated soybeans to Fe3O4 NPs was achieved for the first time using a multicomponent protocol. The U-4C reaction was an efficient and versatile procedure for the conjugation of bioactive peptide fractions to Fe3O4 NPs. The experiments on the RP and hydroxyl radical scavenging activity demonstrated that the antioxidant capacity of the peptide fractions was maintained or increased after the conjugation. The only exception was the conjugation of the >10 kDa peptide fraction to the magnetite NPs coated with sodium citrate (conjugate 1). Its RP decreased slightly with respect to the nonconjugated peptide fraction. Fe3O4@APTES@ > 10 kDa showed the highest antioxidant capacity. The obtained results suggest a synergistic effect of the conjugation of peptide fractions from germinated soybeans to the coated Fe3O4 NPs by the U-4C reaction.

Author Contributions

Conceptualization, H.Y.-M., R.M.-E., Y.E.A.-J. and C.D.-Á.; Methodology, Y.E.A.-J., M.G.-M., D.U.-R., E.C.-U. and D.N.-F.; Validation, H.Y.-M. and R.M.-E.; Formal analysis, Y.E.A.-J.; Investigation, Y.E.A.-J.; Resources, R.M.-E. and H.Y.-M.; Writing, Y.E.A.-J. and R.M.-E.; Supervision, R.M.-E., H.Y.-M., C.D.-Á. and E.C.-U.; Funding acquisition, R.M.-E. and H.Y.-M. All authors have read and agreed to the published version of the manuscript.

Funding

This research was supported by grants from Instituto Politécnico Nacional (SIP:20181718 project) and CONACyT (PY-SEP-CONACyT 242860 project). The work was also supported with a PhD scholarship to A.T.M. from CONACyT.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Data of this research is available from the authors.

Acknowledgments

Y.E.A.J. acknowledges CONACyT for scholarship No. 622043 and H.Y.M. E.C.U. and R.M.E. acknowledge the economic support from EDI, COFAA, and SNI. The authors acknowledge CNMN-IPN and Liliana Alamilla-Beltrán (from ENCB-IPN) for the experimental support provided. Y.E.A.J. is thankful to Eduardo Gonzalez-Martinez and Gerardo-Manuel Ojeda-Carralero for their valuable suggestions.

Conflicts of Interest

The authors declare no conflict of interest.

Sample Availability

Samples of the compounds Fe3O4@APTES@ > 10 kDa are available from the authors.

References

  1. Mahmoudi, M.; Simchi, A.; Imani, M. Recent advances in surface engineering of superparamagnetic iron oxide nanoparticles for biomedical applications. J. Iran. Chem. Soc. 2010, 7, S1–S27. [Google Scholar] [CrossRef]
  2. Corchero, J.L.; Villaverde, A. Biomedical applications of distally controlled magnetic nanoparticles. Trends Biotechnol. 2009, 27, 468–476. [Google Scholar] [CrossRef]
  3. Li, L.; Jiang, W.; Luo, K.; Song, H.; Lan, F.; Wu, Y.; Gu, Z. Superparamagnetic iron oxide nanoparticles as MRI contrast agents for non-invasive stem cell labeling and tracking. Theranostics 2013, 3, 595–615. [Google Scholar] [CrossRef]
  4. Kuznetsov, O.A.; Brusentsov, N.A.; Kuznetsov, A.A.; Yurchenko, N.Y.; Osipov, N.E.; Bayburtskiy, F.S. Correlation of the coagulation rates and toxicity of biocompatible ferromagnetic microparticles. J. Mag. Magn. Mater. 1999, 194, 83–89. [Google Scholar] [CrossRef]
  5. Gómez-Pérez, A.; González-Martínez, E.; Díaz-Águila, C.R.; González-Martínez, D.A.; González-Ruiz, G.; García-Artalejo, A.; Yee-Madeira, H. Chitosan-coated magnetic iron oxide nanoparticles for DNA and rhEGF separation. Coll. Surf. A: Physic. Eng. Aspects 2020, 591, 124500. [Google Scholar] [CrossRef]
  6. González-Martínez, E.; Gómez-Pérez, A.; González-Martínez, D.A.; Díaz-Águila, C.R.; Cristiani-Urbina, E.; Uribe-Ramírez, D.; Yee-Madeira, H. Chitosan-coated magnetic nanoparticles; exploring their potentialities for DNA and Cu(II) recovery. Inor. Nano-Met. Chem. 2021, 51, 1098–1107. [Google Scholar] [CrossRef]
  7. Kogan, M.J.; Olmedo, I.; Hosta, L.; R Guerrero, A.; Cruz, L.J.; Albericio, F. Peptides and metallic nanoparticles for biomedical applications. Nanomedicine 2007, 2, 287–306. [Google Scholar] [CrossRef] [Green Version]
  8. Zhang, W.; Taheri-Ledari, R.; Hajizadeh, Z.; Zolfaghari, E.; Ahghari, M.R.; Maleki, A.; Hamblin, M.R.; Tian, Y. Enhanced activity of vancomycin by encapsulation in hybrid magnetic nanoparticles conjugated to a cell-penetrating peptide. Nanoscale 2020, 12, 3855–3870. [Google Scholar] [CrossRef]
  9. Scarberry, K.E.; Dickerson, E.B.; McDonald, J.F.; Zhang, Z.J. Magnetic nanoparticle−peptide conjugates for in vitro and in vivo targeting and extraction of cancer cells. J. Am. Chem. Soc. 2008, 130, 10258–10262. [Google Scholar] [CrossRef]
  10. Nosrati, H.; Tarantash, M.; Bochani, S.; Charmi, J.; Bagheri, Z.; Fridoni, M.; Abdollahifar, M.-A.; Davaran, S.; Danafar, H.; Kheiri Manjili, H. Glutathione (GSH) peptide conjugated magnetic nanoparticles as blood–brain barrier shuttle for MRI-monitored brain delivery of paclitaxel. ACS Biom. Sci. Eng. 2019, 5, 1677–1685. [Google Scholar] [CrossRef]
  11. Liscano, Y.; Oñate-Garzón, J.; Delgado, J.P. Peptides with dual antimicrobial–anticancer activity: Strategies to overcome peptide limitations and rational design of anticancer peptides. Molecules 2020, 25, 4245. [Google Scholar] [CrossRef]
  12. Gaspar, D.; Veiga, A.S.; Castanho, M.A. From antimicrobial to anticancer peptides. A review. Front. Microbiol 2013, 4, 294. [Google Scholar] [CrossRef] [Green Version]
  13. Jeong, W.-j.; Bu, J.; Kubiatowicz, L.J.; Chen, S.S.; Kim, Y.; Hong, S. Peptide–nanoparticle conjugates: A next generation of diagnostic and therapeutic platforms? Nano Conver. 2018, 5, 38. [Google Scholar] [CrossRef]
  14. Arriortua, O.K.; Garaio, E.; de la Parte, B.H.; Insausti, M.; Lezama, L.; Plazaola, F.; García, J.A.; Aizpurua, J.M.; Sagartzazu, M.; Irazola, M. Antitumor magnetic hyperthermia induced by RGD-functionalized Fe3O4 nanoparticles, in an experimental model of colorectal liver metastases. Beilstein, J. Nano. 2016, 7, 1532–1542. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  15. Yen, S.; Padmanabhan, P.; Selvan, S. Multifunctional iron oxide nanoparticles for diagnostics, therapy and macromolecule delivery. Theranostics 2013, 3, 986–1003. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  16. Wadghiri, Y.Z.; Sigurdsson, E.M.; Sadowski, M.; Elliott, J.I.; Li, Y.; Scholtzova, H.; Tang, C.Y.; Aguinaldo, G.; Pappolla, M.; Duff, K. Detection of Alzheimer’s amyloid in transgenic mice using magnetic resonance microimaging. Magn. Reson. Med. 2003, 50, 293–302. [Google Scholar] [CrossRef] [PubMed]
  17. Arosio, D.; Manzoni, L.; Araldi, E.M.; Scolastico, C. Cyclic RGD functionalized gold nanoparticles for tumor targeting. Bioconjugate Chem. 2011, 22, 664–672. [Google Scholar] [CrossRef]
  18. Ugi, I.; Werner, B.; Dömling, A. The chemistry of isocyanides, their multicomponent reactions and their libraries. Molecules 2003, 8, 53–66. [Google Scholar] [CrossRef] [Green Version]
  19. Weber, L.; Illgen, K.; Almstetter, M. Discovery of new multi component reactions with combinatorial methods. Synlett 1999, 3, 366–374. [Google Scholar] [CrossRef] [Green Version]
  20. Dömling, A.; Ugi, I. Multicomponent reactions with isocyanides. Angew. Chem. Inter. Ed. 2000, 39, 3168–3210. [Google Scholar] [CrossRef]
  21. Rivera, D.G.; Vasco, A.V.; Echemendía, R.; Concepción, O.; Pérez, C.S.; Gavín, J.A.; Wessjohann, L.A. Frontispiece: A ulticomponent conjugation strategy to unique N-steroidal peptides: First evidence of the steroidal nucleus as a β-Turn inducer in acyclic peptides. Chem. Eur. J. 2014, 20, 13150–13161. [Google Scholar] [CrossRef] [PubMed]
  22. Sarmadi, B.H.; Ismail, A. Antioxidative peptides from food proteins: A review. Peptides 2010, 31, 1949–1956. [Google Scholar] [CrossRef] [PubMed]
  23. Branca, F.; Lartey, A.; Oenema, S.; Aguayo, V.; Stordalen, G.A.; Richardson, R.; Arvelo, M.; Afshin, A. Transforming the food system to fight non-communicable diseases. BMJ 2019, 364, l296. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  24. Zhang, C.; Zhou, Y.; Yang, G.-Y.; Li, S. Biomimetic peptides protect cells from oxidative stress. Am. J. Trans. Res. 2017, 9, 5518. [Google Scholar]
  25. Elias, R.J.; Kellerby, S.S.; Decker, E.A. Antioxidant activity of proteins and peptides. C. Food Sci. Nutr. 2008, 48, 430–441. [Google Scholar] [CrossRef]
  26. González-Montoya, M.; Hernández-Ledesma, B.; Silván, J.M.; Mora-Escobedo, R.; Martínez-Villaluenga, C. Peptides derived from in vitro gastrointestinal digestion of germinated soybean proteins inhibit human colon cancer cells proliferation and inflammation. Food Chem. 2018, 242, 75–82. [Google Scholar] [CrossRef] [Green Version]
  27. González-Montoya, M.; Ramón-Gallegos, E.; Robles-Ramírez, M.C.; Mora-Escobedo, R. Evaluation of the antioxidant and antiproliferative effects of three peptide fractions of germinated soybeans on breast and cervical cancer cell lines. PFHN 2016, 71, 368–374. [Google Scholar]
  28. Weissleder, R.; Ross, B.; Rehemtulla, A.; Gambhir, S. General principles of molecular imaging. In Molecular Imaging: Principles and Practice; PMPH: Shelton, CT, USA, 2010; pp. 1–9. [Google Scholar]
  29. Li, L.; Mak, K.; Leung, C.W.; Chan, K.; Chan, W.; Zhong, W.; Pong, P. Effect of synthesis conditions on the properties of citric-acid coated iron oxide nanoparticles. Microelectron. Eng. 2013, 110, 329–334. [Google Scholar] [CrossRef]
  30. Freire, T.; Dutra, L.M.; Queiroz, D.; Ricardo, N.; Barreto, K.; Denardin, J.; Wurm, F.R.; Sousa, C.; Correia, A.; de Lima-Neto, P. Fast ultrasound assisted synthesis of chitosan-based magnetite nanocomposites as a modified electrode sensor. Carb. Polym. 2016, 151, 760–769. [Google Scholar] [CrossRef]
  31. Bini, R.A.; Marques, R.F.C.; Santos, F.J.; Chaker, J.A.; Jafelicci Jr, M. Synthesis and functionalization of magnetite nanoparticles with different amino-functional alkoxysilanes. J. Magnet. Magn. Mat. 2012, 324, 534–539. [Google Scholar] [CrossRef] [Green Version]
  32. Basolo, F.; Johnson, R.; Busch, R.H. Química Compuestos de Coordinación; Reverté: Barcelona, Spain, 1980; pp. 1–178. [Google Scholar]
  33. El Kaim, L.; Grimaud, L. Beyond the Ugi reaction: Less conventional interactions between isocyanides and iminium species. Tetrahedron 2009, 65, 2153–2171. [Google Scholar] [CrossRef]
  34. Reguera, L.; Méndez, Y.; Humpierre, A.R.; Valdés, O.; Rivera, D.G. Multicomponent reactions in ligation and bioconjugation chemistry. Acc. Chem. Res. 2018, 51, 1475–1486. [Google Scholar] [CrossRef] [PubMed]
  35. Morales, F.E.; Garay, H.E.; Muñoz, D.F.; Augusto, Y.E.; Otero-González, A.J.; Reyes Acosta, O.; Rivera, D.G. Aminocatalysis-mediated on-resin ugi reactions: Application in the solid-phase synthesis of n-substituted and tetrazolo lipopeptides and peptidosteroids. Org. Lett. 2015, 17, 2728–2731. [Google Scholar] [CrossRef] [PubMed]
  36. Vega, C.; Delgado-Olivares, L.; Morales González, J.A.; García, E.A.; Villagomez Ibarra, R.J.; Moreno, E.R.; Gutiérrez, M.S.; Sumaya Martínez, M.T.; Clara, Z.P.; Ramos, Z.C. The role of natural antioxidants in cancer disease, oxidative stress and chronic degenerative diseases. In Oxidative Stress and Chronic Degenerative Diseases—A Role for Antioxidants; Morales-Gonzalez, J.A., Ed.; IntechOpen: London, UK, 2013; pp. 391–418. [Google Scholar]
  37. Laurent, S.; Forge, D.; Port, M.; Roch, A.; Robic, C.; Vander Elst, L.; Muller, R.N. Magnetic iron oxide nanoparticles: Synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications. Chem. Rev. 2008, 108, 2064–2110. [Google Scholar] [CrossRef]
  38. Hach Company. DR/890 Colimeter Procedures Manual. Available online: http://www.hach.com (accessed on 15 February 2020).
  39. Bradford, M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72, 248–254. [Google Scholar] [CrossRef]
  40. Oyaizu, M. Studies on products of browning reaction. Jpn. J. Nutr. Deiet. 1986, 44, 307–315. [Google Scholar] [CrossRef] [Green Version]
  41. Lin, S.-Y.; Wang, C.-C.; Lu, Y.-L.; Wu, W.-C.; Hou, W.-C. Antioxidant, anti-semicarbazide-sensitive amine oxidase, and anti-hypertensive activities of geraniin isolated from Phyllanthus urinaria. Food Chem. Toxic. 2008, 46, 2485–2492. [Google Scholar] [CrossRef] [PubMed]
Scheme 1. Experimental workflow.
Scheme 1. Experimental workflow.
Molecules 26 05726 sch001
Figure 1. XRD patterns of the uncoated magnetite (Fe3O4) and magnetite samples coated with sodium citrate (Fe3O4@citrate) and APTES (Fe3O4@APTES).
Figure 1. XRD patterns of the uncoated magnetite (Fe3O4) and magnetite samples coated with sodium citrate (Fe3O4@citrate) and APTES (Fe3O4@APTES).
Molecules 26 05726 g001
Figure 2. Microscopy image of uncoated Fe3O4 with the corresponding histogram.
Figure 2. Microscopy image of uncoated Fe3O4 with the corresponding histogram.
Molecules 26 05726 g002
Figure 3. IR spectra of the uncoated magnetite (Fe3O4) and magnetite samples coated with sodium citrate (Fe3O4@citrate) and APTES (Fe3O4@APTES).
Figure 3. IR spectra of the uncoated magnetite (Fe3O4) and magnetite samples coated with sodium citrate (Fe3O4@citrate) and APTES (Fe3O4@APTES).
Molecules 26 05726 g003
Figure 4. Microscopy images of (a) Fe3O4@citrate and (b) Fe3O4@APTES with the corresponding histograms.
Figure 4. Microscopy images of (a) Fe3O4@citrate and (b) Fe3O4@APTES with the corresponding histograms.
Molecules 26 05726 g004
Figure 5. Percentages of unconjugated peptides to coated Fe3O4: (a) Fe3O4@citrate@ > 10 kDa, Fe3O4@citrate@ > 5–10 kDa; (b) Fe3O4@APTES@ 10 kDa, Fe3O4@APTES@ 5–10 kDa. The determinations were carried out in triplicate. The results are expressed as the means ± standard deviation. Different letters indicate statistical difference between the samples for each reaction time (p ≤ 0.05).
Figure 5. Percentages of unconjugated peptides to coated Fe3O4: (a) Fe3O4@citrate@ > 10 kDa, Fe3O4@citrate@ > 5–10 kDa; (b) Fe3O4@APTES@ 10 kDa, Fe3O4@APTES@ 5–10 kDa. The determinations were carried out in triplicate. The results are expressed as the means ± standard deviation. Different letters indicate statistical difference between the samples for each reaction time (p ≤ 0.05).
Molecules 26 05726 g005
Figure 6. FTIR spectra of the final conjugates: Fe3O4@citrate@ > 10 kDa (conjugate 1), Fe3O4@citrate@ 5–10 kDa (conjugate 2), Fe3O4@APTES@ > 10 kDa (conjugate 3), and Fe3O4@APTES@ 5–10 kDa (conjugate 4).
Figure 6. FTIR spectra of the final conjugates: Fe3O4@citrate@ > 10 kDa (conjugate 1), Fe3O4@citrate@ 5–10 kDa (conjugate 2), Fe3O4@APTES@ > 10 kDa (conjugate 3), and Fe3O4@APTES@ 5–10 kDa (conjugate 4).
Molecules 26 05726 g006
Figure 7. Average results of the RPs of coated magnetite (Fe3O4@APTES and Fe3O4@citrate) and of the conjugates and nonconjugated peptide fractions at 15 mg/mL: Fe3O4@citrate@ > 10 kDa (conjugate 1), Fe3O4@citrate@ 5–10 kDa (conjugate 2), Fe3O4@APTES@ > 10 kDa (conjugate 3), Fe3O4@APTES@ 5–10 kDa (conjugate 4), and nonconjugated peptide fractions (>10 kDa and 5–10 kDa peptide fractions). The determinations were carried out in triplicate. The results are expressed as the means ± standard deviation. Different letters indicate statistical difference between the samples (p ≤ 0.05).
Figure 7. Average results of the RPs of coated magnetite (Fe3O4@APTES and Fe3O4@citrate) and of the conjugates and nonconjugated peptide fractions at 15 mg/mL: Fe3O4@citrate@ > 10 kDa (conjugate 1), Fe3O4@citrate@ 5–10 kDa (conjugate 2), Fe3O4@APTES@ > 10 kDa (conjugate 3), Fe3O4@APTES@ 5–10 kDa (conjugate 4), and nonconjugated peptide fractions (>10 kDa and 5–10 kDa peptide fractions). The determinations were carried out in triplicate. The results are expressed as the means ± standard deviation. Different letters indicate statistical difference between the samples (p ≤ 0.05).
Molecules 26 05726 g007
Figure 8. Average results of the OH· scavenging activities of coated magnetite (Fe3O4@APTES and Fe3O4@citrate) and of the conjugates and nonconjugated peptide fractions at 15 mg/mL: Fe3O4@citrate@ > 10 kDa (conjugate 1), Fe3O4@citrate@ 5–10 kDa (conjugate 2), Fe3O4@APTES@ > 10 kDa (conjugate 3), Fe3O4@APTES@ 5–10 kDa (conjugate 4), and nonconjugated peptide fractions (>10 kDa and 5–10 kDa peptide fractions). The determinations were carried out in triplicate. The results are expressed as the means ± standard deviation. Different letters indicate statistical differences between the samples (p ≤ 0.05).
Figure 8. Average results of the OH· scavenging activities of coated magnetite (Fe3O4@APTES and Fe3O4@citrate) and of the conjugates and nonconjugated peptide fractions at 15 mg/mL: Fe3O4@citrate@ > 10 kDa (conjugate 1), Fe3O4@citrate@ 5–10 kDa (conjugate 2), Fe3O4@APTES@ > 10 kDa (conjugate 3), Fe3O4@APTES@ 5–10 kDa (conjugate 4), and nonconjugated peptide fractions (>10 kDa and 5–10 kDa peptide fractions). The determinations were carried out in triplicate. The results are expressed as the means ± standard deviation. Different letters indicate statistical differences between the samples (p ≤ 0.05).
Molecules 26 05726 g008
Table 1. Determination of the degree of substitution on the MNPs using the bicinchoninate method.
Table 1. Determination of the degree of substitution on the MNPs using the bicinchoninate method.
Particlet (h)Cu2+ Adsorption Capacity
(mg Cu2+/g MNPs)
Amount
(mmol of Free Groups/g MNPs)
Fe3O4@citrate000
Fe3O4@citrate1140.44
Fe3O4@citrate24150.47
Fe3O4@APTES000
Fe3O4@APTES1120.76
Fe3O4@APTES24120.76
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Augusto-Jimenez, Y.E.; González-Montoya, M.; Naranjo-Feliciano, D.; Uribe-Ramírez, D.; Cristiani-Urbina, E.; Díaz-Águila, C.; Yee-Madeira, H.; Mora-Escobedo, R. Antioxidant Activity of Bioactive Peptide Fractions from Germinated Soybeans Conjugated to Fe3O4 Nanoparticles by the Ugi Multicomponent Reaction. Molecules 2021, 26, 5726. https://doi.org/10.3390/molecules26195726

AMA Style

Augusto-Jimenez YE, González-Montoya M, Naranjo-Feliciano D, Uribe-Ramírez D, Cristiani-Urbina E, Díaz-Águila C, Yee-Madeira H, Mora-Escobedo R. Antioxidant Activity of Bioactive Peptide Fractions from Germinated Soybeans Conjugated to Fe3O4 Nanoparticles by the Ugi Multicomponent Reaction. Molecules. 2021; 26(19):5726. https://doi.org/10.3390/molecules26195726

Chicago/Turabian Style

Augusto-Jimenez, Yarelys Elena, Marcela González-Montoya, Dany Naranjo-Feliciano, Daniel Uribe-Ramírez, Eliseo Cristiani-Urbina, Carlos Díaz-Águila, Hernani Yee-Madeira, and Rosalva Mora-Escobedo. 2021. "Antioxidant Activity of Bioactive Peptide Fractions from Germinated Soybeans Conjugated to Fe3O4 Nanoparticles by the Ugi Multicomponent Reaction" Molecules 26, no. 19: 5726. https://doi.org/10.3390/molecules26195726

APA Style

Augusto-Jimenez, Y. E., González-Montoya, M., Naranjo-Feliciano, D., Uribe-Ramírez, D., Cristiani-Urbina, E., Díaz-Águila, C., Yee-Madeira, H., & Mora-Escobedo, R. (2021). Antioxidant Activity of Bioactive Peptide Fractions from Germinated Soybeans Conjugated to Fe3O4 Nanoparticles by the Ugi Multicomponent Reaction. Molecules, 26(19), 5726. https://doi.org/10.3390/molecules26195726

Article Metrics

Back to TopTop